Cost-Effectiveness of Insulin Degludec/Insulin Aspart (IDEGASP) Compared with Biphasic Insulin Aspart (BIASP 30) in Patients with Type 2 Diabetes Mellitus from a Mexican Healthcare Perspective
Nov 1, 2016, 00:00 AM
10.1016/j.jval.2016.09.1873
https://www.valueinhealthjournal.com/article/S1098-3015(16)33239-9/fulltext
Section Title :
Disease-Specific Studies
Section Order :
1772
First Page :
A672
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)33239-9&doi=10.1016/j.jval.2016.09.1873